Current data cannot satisfy the needs of such analyses of other underlying factors, such as age, ECOG performance, histological types, tumor PD‐L1 expression, NSCLC‐associated genes driver mutation status, the dose of RT, different irradiated sites, etc. However, we still found meaningful results which may provide reference to clinicians. This evidence concerns the gene CD274 and non-small cell lung carcinoma.